Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT06208241
EARLY_PHASE1

Use of Allocetra-OTS in End Stage Knee Osteoarthritis - Assessment of Safety

Sponsor: Amir Oron

View on ClinicalTrials.gov

Summary

This is a pilot study to assess safety and possible efficacy of Allocetra-OTS in end-stage knee osteoarthritis.

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

18

Start Date

2023-07-12

Completion Date

2025-12-30

Last Updated

2025-08-05

Healthy Volunteers

No

Interventions

DRUG

Allocetra-OTS

Allocetra-OTS is a cell-based therapy consisting of non-HLA-matched allogeneic peripheral blood mononuclear cells, derived from a healthy human donor following a leukapheresis procedure, induced to an apoptotic stable state and suspended in a solution containing DMSO.

Locations (1)

Kaplan Medical Center

Rehovot, Israel